Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-11-22
1999-08-31
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514381, 514522, 514533, 514534, 514561, 514562, 514563, 514602, 514603, 514618, 514619, 548253, 558415, 558416, 560 17, 562427, 562455, 564 84, 564 85, 564 86, 564 88, 564162, 564168, A61K 3124, C07C22900
Patent
active
059454504
ABSTRACT:
##STR1## (wherein A is a hydrogen atom, a hydroxy group, a C.sub.7 -C.sub.11 aralkyloxy group, or an alkoxy group composed of an oxy group and a C.sub.1 -C.sub.12 aliphatic or alicyclic, saturated or unsaturated hydrocarbon group where the allyl may be substituted with a C.sub.6 -C.sub.10 allyloxy group; Q represents O, S, CH.sub.2, O--CH.sub.2, S--CH.sub.2, CO, or CHOR.sup.1 ; L represents CO, CR.sup.2 R.sup.3 CO, CH.sub.2 CH.sub.2 CO, or CH.dbd.CHCO; D represents a hydrogen atom, NO.sub.2, NH.sub.2, CO.sub.2 R.sup.4, or a group having the following ##STR2## (wherein G represents. a hydrogen atom, OH, SO.sub.2 NH.sub.2, CO.sub.2 R.sup.6, CN, or a tetrazol-5-yl group); E represents a hydrogen atom, OH, SO.sub.2 NH.sub.2, CO.sub.2 R.sup.5, CN, or a tetrazol-5-yl group; M represents a hydrogen atom, a C.sub.1 -C.sub.4 lower alkyl group, a nitro group, or a halogen atom; and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are, independently each other, a hydrogen atom or a C.sub.1 -C.sub.4 lower alkyl group);
REFERENCES:
patent: 3264378 (1966-08-01), Dailey et al.
patent: 4990650 (1991-02-01), Hazato et al.
Department of Bacteriology, Department of Opthamology, School of Medicine, Iwate Medical University, Japan Opthalmol. Soc. 1993 pp. 792-799 Kazuhiro Takahashi, "Participation of Procoagulant Activity of Cultured Rabbit Lens Epithelial Cells in Fibrin Formulation".
European Journal of Medicinal Chemistry, vol. 26, Mar. 1991, pp. 159-166, Murray, et al. Novel 6-oxo-6-naphthylhexaonic acid derivatives with anti-inflammatory and 5-lipoxygenase Inhibitory Activity.
Helvetica Chimica Acta, vol. 39, (1956), pp. 1892-1899, Chardonnens et al. Sur l'aptitude reactionnelle du groupement methylique XIV), Influence des groupements .alpha.- et .beta.-naphtoyles.
Biochemical and Biophysical Research Communications, vol. 119, Feb. 29, 1984, Crutchley, pp. 179-184 "Effects of Inhibitors of Arachidonic Acid Metabolism on Thromboplastin Activity in Human Monocytes".
Chardonnens et.al., Helv. Chim. Acta, vol. XXXIX, No. 224, pp. 1892-1899, 1956.
International Search Report.
Hasegawa Masaichi
Komoriya Keiji
Takahashi Katsushi
Takenouchi Kazuya
Takeuchi Takahiro
Kumar Shailendra
Teijin Limited
LandOfFree
Naphthalene derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalene derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalene derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426614